Germany: Consumer Protection Business Lanxess to Acquire Emerald Kalama Chemical for 1.04 Billion Dollars
Under the terms of the contract, Lanxess will acquire Emerald Kalama Chemical which achieved sales of 425 million dollars and an Ebitda of 90 million dollars last year. With this move, the Germany-based company aims to strengthen its Consumer Protection segment.
Cologne/Germany – Lanxess is accelerating its growth course and has signed a binding agreement to acquire 100 per cent shares in Emerald Kalama Chemical on February 14, 2021. The US-based company is a globally leading manufacturer of specialty chemicals, especially for the consumer segment, and is majority-owned by affiliates of the US private equity firm American Securities.
The enterprise value of Emerald Kalama Chemical amounts to 1.075 billion dollars. After deducting debt-like items, the purchase price is around 1.04 billion dollars (EUR 867 million), which Lanxess will finance from existing liquidity. The transaction is expected to be completed in the second half of 2021. It is still subject to approval by the relevant authorities.
In 2020, Emerald Kalama Chemical achieved sales of around 425 million dollars and Ebitda pre exceptionals of approximately 90 million dollars. Within three years following the completion of the transaction, Lanxess expects an additional annual Ebitda contribution of around 30 million dollars (EUR 25 million) from synergy effects. The acquisition will already be earnings per share accretive in the first fiscal year after its completion.
“We are gaining further momentum on our growth course. The businesses of Emerald Kalama Chemical are an ideal fit for us. We will further strengthen our Consumer Protection segment and open up new application areas with strong margins, for example in the food industry and animal health sector. In addition, we will also enlarge our presence in our growth region of North America. All this will make us even more profitable and stable,” said Matthias Zachert, Chairman of the Board of Management of Lanxess.
Emerald Kalama Chemical employs approximately 500 employees worldwide and runs production sites in Kalama, Washington (USA), Rotterdam (Netherlands) and Widnes (Great Britain). Emerald Kalama Chemical generates around 45 per cent of its turnover in North America. “Emerald Kalama Chemical has a very efficient setup, bundling all its production activities at only three sites. That is why we expect to integrate the new business very quickly,” said Zachert.